Template:Sodium channel blocking toxidromes: Difference between revisions
Neil.m.young (talk | contribs) No edit summary |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
*Antihistamines | *Antihistamines | ||
*Sotalol | *Sotalol | ||
*TCAs | *[[Tricyclic antidepressant (TCA) toxicity|TCAs]] | ||
*Antipsychotics | *Antipsychotics | ||
*Cocaine | *[[Cocaine toxicity|Cocaine]] | ||
*Anti-spasmodics, cyclobenzaprine | *Anti-spasmodics, cyclobenzaprine | ||
*Chloroquine | *Chloroquine | ||
*Anti-malarials | *Anti-malarials | ||
*Class | *Class Ia and Ic antiarrhythmics | ||
*[[Local anesthetic systemic toxicity]] | |||
*[[Venlafaxine]] toxicity | |||
Latest revision as of 13:56, 1 September 2019
Sodium Channel Blockade Toxidrome
- Phenothiazines
- Antihistamines
- Sotalol
- TCAs
- Antipsychotics
- Cocaine
- Anti-spasmodics, cyclobenzaprine
- Chloroquine
- Anti-malarials
- Class Ia and Ic antiarrhythmics
- Local anesthetic systemic toxicity
- Venlafaxine toxicity